GlassScriptPhysician profile
Michael R Probstfeld
NPI 1699782565
$45,625.93
in general payments reported to CMS, 2019-2025
31 companies · $257 in 2025
The $257 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42K · 2020: $1,728 · 2021: $741 · 2022: $943 · 2023: $103 · 2024: $207 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $41,216.20 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $1,372.61 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $381.28 | 2020-2022 | |
| Medtronic, INC. | $298.19 | 2022-2024 | Ligasure |
| Smith+Nephew, INC. | $292.54 | 2019-2022 | |
| Boston Scientific Corporation | $273.99 | 2020-2025 | Spyglass Discover, Spyglass |
| Integra Lifesciences Corporation | $253.42 | 2019-2025 | Gentrix, Integra, Omnigraft |
| Ethicon US, LLC | $251.78 | 2021-2022 | |
| Acacia Pharma INC | $243.09 | 2021 | |
| Covidien LP | $176.84 | 2019-2020 | |
| Tactile Systems Technology INC | $159.66 | 2019-2021 | |
| Organogenesis INC. | $133.52 | 2020-2022 | |
| Tela Bio, INC. | $84.67 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Osiris Therapeutics INC. | $57.63 | 2019 | |
| Merck Sharp & Dohme LLC | $52.95 | 2019-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $48.92 | 2019-2023 | Zilver Ptx |
| Misonix INC | $47.56 | 2019-2021 | |
| Shire North American Group INC | $42.39 | 2019 | |
| Intuitive Surgical, INC. | $34.49 | 2022 | |
| Davol INC. | $25.74 | 2021 | |
| Baxter Healthcare | $21.06 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.05 | 2019 | |
| Merit Medical Systems INC | $20.62 | 2021 | |
| Biocompatibles, INC. | $19.73 | 2019 | |
| Kerecis Limited | $16.61 | 2022 | |
| Myovant Sciences INC. | $15.15 | 2021 | |
| Medela LLC | $13.72 | 2021 | |
| Amgen INC. | $13.62 | 2020 | |
| Innocoll Pharmaceuticals Limited | $12.77 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.23 | 2020 | |
| Abbvie INC. | $11.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Probstfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.